Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fosun Pharma Reorganizes Pharmaceutical Retail Business

This article was originally published in PharmAsia News

Executive Summary

Fosun International's new fully owned subsidiary Qishen Investment will acquire Fosun Grand Drugstore's 40 percent equity in Sinopharm Medicine Holding for 687 million yuan. The investment firm will also buy 7.04 percent stake in Fosun Pharma for 120 million yuan. After the internal share transfer, Foshun Grand's equity owned by Sinopharm, Qishen and Fosun International will be 51, 47.04 and 1.96 percent respectively. Analysts note that Qishen's establishment seeks to consolidate and streamline Fosun's medical retail business; furthermore, as a new setup, Qishen can legally avoid high taxation which the established companies are subject to.(Click here for more - Chinese Language)



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts